Records are supplied by study sponsors and investigators. A registry listing is not an endorsement or a guarantee of safety, availability or eligibility.
WCR feed checked: Nov 11, 2026.
RecruitingNCT07781605
Body Temperature Changes · Heat Stress · Child Development · Heat · Physiological Stress
Not applicable9 years - 25 yearsOttawa, Ontario, Canada Little is known about how children and youth regulate body temperature during exercise across different environmental temperatures compared with young adults, including whether differences in whole-body heat exchange contribute to their responses. Th…
TerminatedNCT05162066
Complement 3 Glomerulopathy · Immunoglobulin A Nephropathy · Membranous Nephropathy
Phase 218 years - Not specifiedPoitiers, France +8 The objective of this study was to determine the safety and therapeutic potential of BCX9930 in participants with C3G, IgAN, or PMN.
CompletedNCT06757075
Pain, Postoperative
Phase 44 years - 6 yearsBrighton, Massachusetts, United States The purpose of this study is to investigate the effectiveness of various oral analgesic regimens in minimizing post-operative pain and discomfort in young children following dental rehabilitation under general anesthesia (DRGA). In this randomized co…
Active, not recruitingNCT06454383
Advanced Pancreatic Adenocarcinoma · Stage III Pancreatic Cancer AJCC v8 · Stage IV Pancreatic Cancer AJCC v8 · Unresectable Pancreatic Ductal Adenocarcinoma
Phase 118 years - Not specifiedDuarte, California, United States This phase Ib trial tests the safety, side effects, and best dose of leflunomide in combination with gemcitabine in treating patients with pancreatic cancer that may have spread from where it first started to nearby tissue, lymph nodes, or distant pa…
CompletedNCT07928557
Multiple Sclerosis
Not applicable20 years - 60 yearsDenizli, Denizli, Turkey (Türkiye) This study aimed to evaluate the effects of Tai Chi exercise on cognitive functions, fatigue, and depressive symptoms in individuals with Multiple Sclerosis (MS). MS is a chronic neurological disease characterized by demyelination within the central …
RecruitingNCT07139769
Caregiving for Cancer
Not applicable18 years - Not specifiedBoston, Massachusetts, United States The study team aims to adapt a psychosocial intervention to reduce psychological distress among the caregiving parents of adolescents and young adults (aged 15-39) who have cancer. First, the study team will adapt an evidence-supported, group-based p…
RecruitingNCT07419295
Bladder Cancer
Phase 318 years - Not specifiedNewport Beach, California, United States +101 Researchers are looking for new ways to treat locally advanced or metastatic urothelial cancer (UC). Current treatments for locally advanced or metastatic UC include chemotherapy, immunotherapy, and targeted therapy. Researchers want to know if givin…
Active, not recruitingNCT06668064
Wet Age Related Macular Degeneration · wAMD
Phase 350 years - Not specifiedPhoenix, Arizona, United States +72 This is a phase 3 randomized, double -masked study comparing the efficacy of EYP-1901 against Aflibercept.
Not yet recruitingNCT07928206
Benign Prostatic Hyperplasia (BPH)
Phase 250 years - 80 yearsLocation not listed A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of RT-310 (Paclitaxel) Protate Implant(s) for Treatment of Lower Urinary Tract Symptoms (LUTS) Secondary to Benign Prostatic Hyperplasia (BPH)
RecruitingNCT07067463
Multiple Sclerosis (MS) Primary Progressive
Phase 318 years - 60 yearsPheonix, Arizona, United States +73 Orelabrutinib is a CNS-penetrable BTK inhibitor. This is a phase 3, randomized, double-blind, parallel-group, multicenter study to evaluate the efficacy and safety of orelabrutinib compared with placebo in patients with PPMS. Patients will be treated…
RecruitingNCT00923507
Waldenstrom Macroglobulinemia · Lymphoplasmacytic Lymphoma · Monoclonal B-Cell Lymphocytosis · Small Lymphocytic Lymphoma · CLL (Chronic Lymphocytic Leukemia)
Observational18 years - 110 yearsBethesda, Maryland, United States Background The development of new technologies now allow scientists to investigate the molecular basis and clinical manifestations of monoclonal B cell lymphocytosis (MBL), chronic lymphocytic leukemia(CLL)/small lymphocytic lymphoma (SLL), lymphopla…
RecruitingNCT07830771
Tuberculosis, Pulmonary
Early Phase 121 years - Not specifiedPhiladelphia, Pennsylvania, United States This is an early phase study in patients with Tuberculosis (TB) to evaluate Fibroblast Activating Protein (FAP) activation as a marker of fibrosis. The Investigators propose to use FAP PET/CT to define the extent and location of FAP signals in lungs …
Retrieved from ClinicalTrials.gov: Nov 11, 2026. Overall study status may differ from a particular location’s status.
